ACADIA PHARMACEUTICALS INC Business Operations Contracts & Agreements
21 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Cooperation Agreements (1)
- Development Agreements (5)
- Services Agreements (8)
- Supply Agreements (4)
- Termination Agreements (2)
- Commercial Supply Agreement, dated March 1, 2023, by and between the Registrant and CoreRx Inc., as amended by Amendment No. 1, dated August 1, 2023 (Filed With SEC on February 28, 2024)
- Commercial Supply Agreement, dated December 15, 2021, by and between the Registrant and F.I.S. Fabbrica Italiana Sintetici S.p.A (Filed With SEC on February 28, 2024)
- Master Commercial Supply Agreement, dated November 16, 2022, by and between the Registrant and Corden Pharma Bergamo S.p.A (Filed With SEC on February 28, 2024)
- Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on February 28, 2024)
- Attachment #4, Attachment #5 and Attachment #6, each dated May 12, 2017, to the Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and... (Filed With SEC on November 3, 2022)
- Change Order #1 to Master Services Agreement Attachment #1, dated January 3, 2017, by and between Acadia Pharmaceuticals GmbH and Siegfried AG (Filed With SEC on November 3, 2022)
- Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and Siegfried AG and its affiliates, and Attachment #1, Attachment #2 and Attachment... (Filed With SEC on November 3, 2022)
- Master Manufacturing Services Agreement and Product Agreement, dated August 3, 2015, by and between the Registrant and Patheon Pharmaceuticals Inc (Filed With SEC on May 6, 2021)
- Attachment #7, dated September 30, 2020, to the Master Services Agreement, dated December 15, 2016, by and between Acadia Pharmaceuticals GmbH and Siegfried AG and its affiliates (Filed With SEC on November 4, 2020)
- Commercial Supply Agreement, dated February 22, 2018, by and between the Registrant and Catalent Pharma Solutions, LLC (Filed With SEC on February 27, 2018)
- Master Services Agreement (Filed With SEC on February 28, 2017)
- Co-operation Agreement (Filed With SEC on November 5, 2015)
- Master Manufacturing Services Agreement August 3, 2015 (Filed With SEC on November 5, 2015)
- Termination Agreement (Filed With SEC on May 10, 2011)
- TERMINATION AGREEMENT (Filed With SEC on March 10, 2011)
- FOURTH AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT (Filed With SEC on August 5, 2009)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 11, 2009)
- THIRD AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT (Filed With SEC on May 5, 2008)
- SECOND AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT (Filed With SEC on March 15, 2006)
- COLLABORATIVE RESEARCH, DEVELOPMENT ANDLICENSE AGREEMENT by andamong ACADIA PHARMACEUTICALSINC., VISIONPHARMACEUTICALS L.P. and ALLERGAN, INC. (Filed With SEC on May 25, 2004)
- COLLABORATIVE RESEARCH, DEVELOPMENT ANDLICENSE AGREEMENT By and Among (Filed With SEC on February 27, 2004)
